PetMed Express
PETS • NASDAQ
PetMed Express is a medical - pharmaceuticals company in the healthcare sector trading on NASDAQ, led by CEO Leslie C. G. Campbell, with a market cap of $63.7M.
CEOLeslie C. G. Campbell
Market Cap$63.7M
Medical - Pharmaceuticals
Healthcare
Employees287.0
Websitepetmeds.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for PetMed Express
Date
Friday, February 20, 2026 (in 1 week)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.13
Revenue Estimate
$20.0M
Earnings History
Past 10 earnings reports for PetMed Express
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Oct 14, 2025 | Q4 2025 | -$0.56Est: -$0.28 | -100.0% | $46.5MEst: $21.8M | +112.8% |  10-K |
| Feb 10, 2025 | Q3 2025 | -$0.03Est: $0.00 | — | $53.0MEst: $60.0M | -11.7% | 10-Q |
| Nov 6, 2024 | Q2 2025 | $0.11Est: -$0.05 | +320.0% | $59.6MEst: $66.0M | -9.7% | 10-Q |
| Aug 6, 2024 | Q1 2025 | $0.18Est: -$0.09 | +300.0% | $68.0MEst: $75.0M | -9.4% | 10-Q |
| Jun 11, 2024 | Q4 2024 | -$0.25Est: -$0.03 | -733.3% | $66.5MEst: $79.4M | -16.3% | 10-K |
| Apr 15, 2024 | Q3 2024 | -$0.10Est: -$0.01 | -900.0% | $65.3MEst: $65.0M | +0.5% | 10-Q/A |
| Oct 30, 2023 | Q2 2024 | $0.00Est: $0.08 | -100.0% | $71.0MEst: $76.0M | -6.6% | — |
| Jul 31, 2023 | Q1 2024 | $0.03Est: $0.07 | -57.1% | $78.2MEst: $79.4M | -1.5% | — |
| May 22, 2023 | Q4 2023 | $0.04Est: $0.14 | -71.4% | $62.4MEst: $65.8M | -5.1% | — |
| Feb 6, 2023 | Q3 2023 | $0.00Est: $0.20 | -100.0% | $58.9MEst: $62.0M | -5.1% | — |